Merck & Co., Inc. Drug Shows Promise in Pelvic Cancer Patients

Reuters -- An anti-cancer pill from Merck & Co (MRK.N) can fight tumours and is safe in combination with palliative radiotherapy for patients with advanced pelvic cancer, data from early stage trials showed on Wednesday.